Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone-Reference-Cited by-同舟云学术

Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone

Published:2021-07-12 Issue:10 Volume:96 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Sanchez Larysa¹^ORCID,Leleu Xavier²,Beaumont Jennifer L.³^ORCID,Yu Hailin³,Hudgens Stacie³,Simonova Maryana⁴,Auner Holger W.⁵^ORCID,Quach Hang⁶,Delimpasi Sosana⁷,Špička Ivan⁸,Pour Ludĕk⁹,Kriachok Iryna¹⁰,Dimopoulos Meletios A.¹¹^ORCID,Usenko Ganna¹²,Hájek Roman¹³,Benjamin Reuben¹⁴,Sinha Dinesh Kumar¹⁵,Venner Christopher¹⁶,Illmer Thomas¹⁷,Garg Mamta Krishnan¹⁸,Stevens Don Ambrose¹⁹,Jagannath Sundar¹,Levy Moshe²⁰,Anderson Larry D.²¹,Bahlis Nizar Jacques²²,Facon Thierry²³,Cavo Michele²⁴,Chai Yi²⁵,Ma Xiwen²⁵,Tang Shijie²⁵,Leong Hoyee²⁵,Shah Jatin²⁵,Shacham Sharon²⁵,Kauffman Michael²⁵,Richardson Paul²⁶,Grosicki Sebastian²⁷

Affiliation:

1. Icahn School of Medicine at Mount Sinai New York New York USA

2. CHU de Poitiers ‐ Hôpital La Milétrie Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie Poitiers France

3. Clinical Outcomes Solutions Tucson Arizona USA

4. Institute of Blood Pathology & Transfusion Medicine of National Academy of Medical Sciences of Ukraine Lviv Ukraine

5. Hugh and Josseline Langmuir Centre for Myeloma Research Imperial College London London UK

6. St Vincent's Hospital University of Melbourne Melbourne Victoria Australia

7. Evangelismos Hospital Hematology/Lymphomas and BMT Unit Athens Greece

8. 1st Internal Clinic ‐ Clinic of Hematology General University Hospital in Prague Prague Czechia

9. University Hospital Brno Clinic of Internal Medicine ‐ Hematology and Oncology Brno Czechia

10. Scientific Research Department of Chemotherapy of Hemoblastoses and Adjuvant Treatment Methods National Cancer Institute Rockville Maryland USA

11. Department of Clinical Therapeutics National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital Athens Greece

12. City Clinical Hospital No.4 of Dnipro City Council City Hematology Center Dnipro Ukraine

13. Department of Hemato‐oncology University Hospital Ostrava Ostrava Czechia

14. Kings College Hospital NHS Foundation Trust London UK

15. State Cancer Institute Indira Gandhi Institute of Medical Sciences, Patna India

16. Cross Cancer Institute, University of Alberta Edmonton Alberta Canada

17. Group Practice for Hematology and Oncology Dresden Germany

18. University Hospitals of Leicester NHS Trust Leicester UK

19. Norton Cancer Institute‐ St. Matthews Louisville Kentucky USA

20. Baylor University Medical Center Dallas Texas USA

21. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas USA

22. University of Calgary Charbonneau Cancer Research Institute Calgary Alberta Canada

23. CHU Lille Service des Maladies du Sang Lille France

24. Policlinico S. Orsola‐Malpighi Bologna Italy

25. Karyopharm Therapeutics Newton Massachusetts USA

26. Dana‐Farber Cancer Institute Boston Massachusetts USA

27. Medical University of Silesia Katowice Poland

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26282

Reference6 articles.

1. ACS.Key statistics for multiple myeloma.2021.https://www.cancer.org/cancer/multiple‐myeloma/about/key‐statistics.html. Accessed June 01 2021.

2. Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

3. Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020

4. Management of treatment-emergent peripheral neuropathy in multiple myeloma

5. Network NCC.What is peripheral neuropathy.2021.https://www.nccn.org/patients/resources/life_with_cancer/managing_symptoms/neuropathy.aspx. Accessed January 21 2021.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Meaningful Change Thresholds for EORTC QLQ-C30 and FACT-G Within Oncology;Value in Health;2024-04

2. Pain management in patients with multiple myeloma;Douleurs : Évaluation - Diagnostic - Traitement;2024-02

3. Selinexor: Targeting a novel pathway in multiple myeloma;eJHaem;2023-05-15

4. Selinexor–Bortezomib–Dexamethasone: A Review in Previously Treated Multiple Myeloma;Targeted Oncology;2023-01-09

5. How I approach smoldering multiple myeloma;Blood;2022-08-25